DIAZEPAM ALKALOID 10 mg/2 mL rastvor za injekciju Bosna in Hercegovina - hrvaščina - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

diazepam alkaloid 10 mg/2 ml rastvor za injekciju

alkaloid d.o.o. sarajevo - diazepam - rastvor za injekciju - 10 mg/2 ml - 2 ml rastvora za injekciju sadrži: 10 mg diazepama

Cefaleksin Belupo 250 mg/5 ml prašak za oralnu suspenziju Hrvaška - hrvaščina - HALMED (Agencija za lijekove i medicinske proizvode)

cefaleksin belupo 250 mg/5 ml prašak za oralnu suspenziju

belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica, hrvatska - cefaleksin hidrat - prašak za oralnu suspenziju - 250 mg/5 ml - urbroj: bočica s praškom za oralnu suspenziju sadrži 5 g cefaleksina u obliku cefaleksin hidrata; 5 ml pripremljene suspenzije sadrži 250 mg cefaleksina u obliku cefaleksin hidrata

Salofalk 4 g/60 ml rektalna suspenzija Hrvaška - hrvaščina - HALMED (Agencija za lijekove i medicinske proizvode)

salofalk 4 g/60 ml rektalna suspenzija

dr. falk pharma gmbh, leinenweberstraße 5, freiburg, njemačka - mesalazin - rektalna suspenzija - 4 g/60 ml - urbroj: 1 bočica sadrži 4 g mesalazina

Diflucan 10 mg/ml prašak za oralnu suspenziju Hrvaška - hrvaščina - HALMED (Agencija za lijekove i medicinske proizvode)

diflucan 10 mg/ml prašak za oralnu suspenziju

pfizer croatia d.o.o., slavonska avenija 6, zagreb, hrvatska - flukonazol - prašak za oralnu suspenziju - 10 mg/ml - urbroj: 1 ml pripremljene suspenzije sadrži 10 mg flukonazola

Megostat 40 mg/ml oralna suspenzija Hrvaška - hrvaščina - HALMED (Agencija za lijekove i medicinske proizvode)

megostat 40 mg/ml oralna suspenzija

bausch health ireland limited, 3013 lake drive, citywest business campus, dublin 24, irska - megestrolacetat - oralna suspenzija - 40 mg/ml - urbroj: 1 ml suspenzije sadrži 40 mg mikroniziranog megestrolacetata

Metadon Alkaloid 10 mg/ml oralna otopina Hrvaška - hrvaščina - HALMED (Agencija za lijekove i medicinske proizvode)

metadon alkaloid 10 mg/ml oralna otopina

alkaloid d.o.o., slavonska avenija 6 a, zagreb, hrvatska - metadonklorid - oralna otopina - 10 mg/ml - urbroj: 1 ml otopine sadrži 10 mg metadonklorida

Metadon Alkaloid 10 mg/ml oralne kapi, otopina Hrvaška - hrvaščina - HALMED (Agencija za lijekove i medicinske proizvode)

metadon alkaloid 10 mg/ml oralne kapi, otopina

alkaloid d.o.o., slavonska avenija 6 a, zagreb, hrvatska - metadonklorid - oralne kapi, otopina - 10 mg/ml - urbroj: 1 ml otopine (30 kapi) sadrži 10 mg metadonklorida

Herbion sirup od bršljana Hrvaška - hrvaščina - HALMED (Agencija za lijekove i medicinske proizvode)

herbion sirup od bršljana

krka - farma d.o.o., radnička cesta 48, zagreb, hrvatska - suhi ekstrakt bršljanovog lista (5-7,5:1), ekstrakcijsko otapalo: etanol 30% (m/m) - sirup - 7 mg/ml - urbroj: 1 ml sirupa sadrži 7 mg ekstrakta (kao suhi ekstrakt) iz hedera helix l., folium (bršljanov list) (5-7,5 : 1); ekstrakcijsko otapalo: etanol 30 % m/m

Cefiksim Nectar 100 mg/5 ml prašak za oralnu suspenziju Hrvaška - hrvaščina - HALMED (Agencija za lijekove i medicinske proizvode)

cefiksim nectar 100 mg/5 ml prašak za oralnu suspenziju

neclife pt unipessoal, lda., rua brito pais 8c, alges, portugal - cefiksim trihidrat - prašak za oralnu suspenziju - 100 mg/5 ml - urbroj: svakih 5 ml pripremljene suspenzije sadržava cefiksim trihidrat što odgovara 100 mg cefiksima

Jayempi Evropska unija - hrvaščina - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azathioprine - odbacivanje transplantata - imunosupresivi - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.